Atlas market file · Equity · United States
EQV Ventures Acquisition Corp. IIEVAC
- Last close
- 10.26
- Change
- +0.00%
- 96-bar range
- 10.07 – 10.29
- As of
- 5 Aug 2026
EQV Ventures Acquisition Corp. II is a blank checks issuer listed as EVAC on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 52 weekly closes (+3.12% over the window).
Source rail: Yahoo Finance chart API (EVAC). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for EVAC. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
EVAC public profile
Blank checks issuer. EQV Ventures Acquisition Corp. II is connected to current market context, cited company sources and its retained research file.
EQV Ventures Acquisition Corp. II trades as EVAC on NYSE. EQV Ventures Acquisition Corp. II (EVAC) has a latest verified close of 10.26, unchanged, dated 5 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files EVAC under USA Stocks for browsing.
What changed for EQV Ventures Acquisition Corp. II today
EQV Ventures Acquisition Corp. II, the blank-cheque vehicle that promised to hunt for a target while investors waited patiently, has filed its latest quarterly accounts and the numbers read like a cautionary tale about the limits of SPAC promises. The company closed the quarter to 31 March 2026 with $1.5 million in cash, $474.4 million in assets, and $18.4 million in liabilities, leaving shareholders staring at a $16.3 million deficit in equity. The quarter also delivered a net income of $3.9 million and an operating loss of $427,850, while operating cash flow drained $121,028. These are not the metrics of a business that has found its footing; they are the ledger entries of an entity that survives on hope and accounting entries rather than revenues or customers.
If the purpose of EQV Ventures II is to deploy capital into an operating business, the absence of any disclosed target or revenue-generating activity in the 10-Q suggests the capital remains largely uninvested. The company’s structure centres on a continuing board whose advance approval is required for acquisitions, a governance arrangement that places the directors’ discretion at the heart of the investment process. The indemnification agreements and amended articles of association are dense with legal protections for directors and the company’s sponsors, yet the balance sheet remains thin gruel. Warrants are duly documented in the specimen certificate, but the underlying economics-who holds them, their exercise terms, and their dilution impact-are buried in the fine print rather than disclosed in the profit-and-loss line.
The 10-Q for the quarter ending 31 March 2026 reports net income attributable to parent of $3.9 million, operating income of negative $427,850, total assets of $474.4 million, total liabilities of $18.4 million, and shareholders’ equity of negative $16.3 million. Cash and cash equivalents at 31 March 2026 stood at $1.5 million, while net cash used in operating activities was $121,028. These figures are taken directly from the 10-Q filed 15 May 2026 and the supporting XBRL data on SEC EDGAR. (source: EQV Ventures Acquisition Corp. II 10-Q for period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/2042902/000121390026057687/ea0290856-10q_eqvventures2.htm; EQV Ventures Acquisition Corp. II company facts JSON, https://data.sec.gov/api/xbrl/companyfacts/CIK0002042902.json)
The company’s filings confirm that the continuing directors retain advance approval rights over acquisitions and that indemnification agreements are baked into the corporate documents. The 8-K filed on 9 July 2026 is a parade of exhibits: indemnification agreements, amended articles, and specimen warrant certificates, all designed to keep the lights on while the cash balance stays stubbornly low. The filing is a monument to process, but the cash position is a monument to fragility. The 13G filing from 2 February 2026 shows shareholder composition, but it does not reveal the identity or intentions of the beneficial owners behind the structure. The evidence does not disclose any revenue-generating business, pipeline, or customer contracts; the operating activity is cash burn and accounting entries rather than commercial activity.
For readers who like their market stories with a chart, the SEC submissions JSON and company facts JSON contain pointers to structured data but do not themselves produce a price chart or trading levels. The company’s shares trade on the Nasdaq Capital Market under the ticker EVAC, but the filings do not include any trading volume, price history, or liquidity metrics. The absence of disclosed commercial operations and the negative equity position mean the stock’s behaviour is driven by narrative and liquidity mechanics rather than fundamental performance. (source: EQV Ventures Acquisition Corp. II SEC submissions JSON, https://data.sec.gov/submissions/CIK0002042902.json; EQV Ventures Acquisition Corp. II company facts JSON, https://data.sec.gov/api/xbrl/companyfacts/CIK0002042902.json; EQV Ventures Acquisition Corp. II 8-K filed 2026-07-09, https://www.sec.gov/Archives/edgar/data/2042902/000121390026076713/ea0297072-8k_eqvvent2.htm)
What changed this week: the 8-K filed on 9 July 2026 is a procedural update rather than a commercial milestone. The board approved routine matters and reiterated the advance-approval mechanism for acquisitions, but the company did not announce a target, revenue, or capital deployment. The operating cash burn continues, the equity hole deepens, and the warrants remain on the books as promises without performance. The filing is a reminder that SPACs exist in a regulatory and governance framework, but the balance sheet remains the ultimate arbiter of value. Until the company discloses a target or operational revenue, the file is a ledger of potential rather than achievement.
What remains unproven: there is no evidence in the filings of an operating business, customer contracts, platform metrics, or product pipeline. The indemnification agreements and amended articles are corporate hygiene rather than commercial proof. The only concrete fact is the cash position and the operating cash burn, which together describe a company that is consuming capital while waiting for a story to tell. The evidence does not show guidance, segment performance, or any metric that would allow an external observer to assess the quality or timing of a potential acquisition. The company’s continued existence depends on the continuing directors’ discretion and the sponsors’ ability to maintain the capital structure, neither of which is a substitute for commercial performance.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
EVAC technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on EVAC
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep EVAC research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
EVAC FAQ
What is EQV Ventures Acquisition Corp. II (EVAC)?EQV Ventures Acquisition Corp. II (EVAC) has a latest verified close of 10.26, unchanged, dated 5 Aug 2026. Use this page to check the price chart, company context,...
EQV Ventures Acquisition Corp. II (EVAC) has a latest verified close of 10.26, unchanged, dated 5 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for EVAC?EQV Ventures Acquisition Corp. II (EVAC) has a latest verified close of 10.26, unchanged, dated 5 Aug 2026. It brings the latest available chart, company context, cited...
EQV Ventures Acquisition Corp. II (EVAC) has a latest verified close of 10.26, unchanged, dated 5 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files EVAC under USA Stocks for browsing.
How often is the EVAC page updated?The EVAC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The EVAC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for EVAC?The EVAC file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:EVAC. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The EVAC file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:EVAC. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on EVAC?Yes. The workstation can open EVAC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open EVAC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this EVAC page investment advice?No. The EVAC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The EVAC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
EVAC
Equity · evidence first